Clinical Trial Update: Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a multi-drug regimen combining either Abiraterone Acetate or Enzalutamide with Atezolizumab, a GnRH analog, and radiation therapy in me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)
• Atezolizumab (atezolizumab)
• Enzalutamide (enzalutamide)
• GnRH analog

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Metastatic Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-04-24